Grape King Bio (TPE:1707) Interest Coverage : 1,050.60 (As of Dec. 2024)

View and export this data going back to 1982. Start your Free Trial

What is Grape King Bio Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Grape King Bio's Operating Income for the three months ended in Dec. 2024 was NT$763 Mil. Grape King Bio's Interest Expense for the three months ended in Dec. 2024 was NT$-1 Mil. Grape King Bio's interest coverage for the quarter that ended in Dec. 2024 was 1,050.60. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Grape King Bio Ltd has enough cash to cover all of its debt. Its financial situation is stable.

The historical rank and industry rank for Grape King Bio's Interest Coverage or its related term are showing as below:

TPE:1707' s Interest Coverage Range Over the Past 10 Years
Min: 70.46 Med: 163.61 Max: 1078.51
Current: 823.4

TPE:1707's Interest Coverage is ranked better than
92.11% of 672 companies
in the Drug Manufacturers industry
Industry Median: 12.64 vs TPE:1707: 823.40

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Grape King Bio Interest Coverage Historical Data

The historical data trend for Grape King Bio's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Grape King Bio Interest Coverage Chart

Grape King Bio Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Coverage

Get a 7-Day Free Trial

160.71

576.45

1,078.51

984.69

823.40

Grape King Bio Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Coverage	Get a 7-Day Free Trial															1,144.88	588.50	713.14	942.65	1,050.60

Competitive Comparison of Grape King Bio's Interest Coverage

For the Drug Manufacturers - Specialty & Generic subindustry, Grape King Bio's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grape King Bio's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grape King Bio's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Grape King Bio's Interest Coverage falls into.

Save Embed

;

Save Embed

;

Grape King Bio Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage

-1

Operating Income

Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt ⁽¹⁾.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Grape King Bio's Interest Coverage for the fiscal year that ended in Dec. 2024 is calculated as

Here, for the fiscal year that ended in Dec. 2024, Grape King Bio's Interest Expense was NT$-3 Mil. Its Operating Income was NT$2,500 Mil. And its Long-Term Debt & Capital Lease Obligation was NT$107 Mil.

Interest Coverage	=	-1	*	Operating Income (A: Dec. 2024 )	/	Interest Expense (A: Dec. 2024 )
	=	-1	*	2499.857	/	-3.036
	=	823.40

Grape King Bio's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Here, for the three months ended in Dec. 2024, Grape King Bio's Interest Expense was NT$-1 Mil. Its Operating Income was NT$763 Mil. And its Long-Term Debt & Capital Lease Obligation was NT$107 Mil.

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2024 )	/	Interest Expense (Q: Dec. 2024 )
	=	-1	*	762.733	/	-0.726
	=	1,050.60

The higher the ratio, the stronger the company's Financial Strength is.

Grape King Bio (TPE:1707) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Grape King Bio Interest Coverage Related Terms

Thank you for viewing the detailed overview of Grape King Bio's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

Grape King Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grape King Bio Ltd (TPE:1707) » Definitions » Interest Coverage

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 402, Jinling Road, Section 2, Pingzhen District, Taoyuan, TWN, 324

Website

https://www.grapeking.com.tw

Grape King Bio Ltd is a specialty and generic drug manufacturing company engaged in the production and sales of pharmaceutical preparation, patent medicine, liquid tonic, drink, and healthy food. The company has three segments: MLM (Multi-Level Marketing) is a direct seller of Pro-partner Inc, including the Company's development and manufacturing products for Pro-partner Inc, Distributors segment includes the company's self-owned brand products, and ODM/OEM (Original Design Manufacturer/Original Equipment Manufacturer) includes ODM/OEM in Taiwan and Shanghai. The group operates in three principal geographical areas - Taiwan, China, and Others and it derives a majority of its revenue from Taiwan.

Grape King Bio Headlines

No Headlines